Kill Germs on iPhone 6S and 6S Plus With Revolutionary UV Cell Phone Sanitizer
September 18, 2015 09:23 ET
|
Spectronics Corporation
WESTBURY, NY--(Marketwired - September 18, 2015) - The Centers for Disease Control and Prevention (CDC) has recommended routinely cleaning and disinfecting surfaces that are touched often, including...
C3 Jian Completes Second Phase 2 Clinical Trial of Anti-Cavity Drug
July 13, 2015 06:00 ET
|
C3 Jian, Inc.
LOS ANGELES, July 13, 2015 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a biotechnology company focused on reengineering the human microbiome to deliver novel healthcare products, announced it has preliminary...
C3 Jian Initiates Phase 2 Clinical Trial of Anti-Cavity Drug
March 07, 2014 18:40 ET
|
C3 Jian, Inc.
LOS ANGELES, March 7, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that the first Phase 2 Clinical Trial for its novel drug,...
Global Earth Energy, Inc.'s (GLER) Partner ByoSafe, LLC Provides Report on ByoAg's Agricultural Chemical Product Lines
December 27, 2013 10:00 ET
|
Global Earth Energy, Inc.
WILMINGTON, N.C., Dec. 27, 2013 (GLOBE NEWSWIRE) -- Global Earth Energy, Inc. (OTCQB:GLER) reports on its 20% partner ByoSafe, LLC's 100% owned agricultural chemicals product line,...
When It Comes to Hand Washing, Many Skip the Suds
October 10, 2013 05:00 ET
|
Bradley Corporation
MISSION, KS--(Marketwired - Oct 10, 2013) - (Family Features) According to recent research, 95 percent of Americans admit it is important to wash their hands after using a public restroom. This is...
Fedora Pharmaceuticals Demonstrates that FPI-1465 Increases Activity of Certain Antibiotics against Drug-Resistant Bacteria
September 12, 2013 13:00 ET
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Sept. 12, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. and its collaborators presented
results of preclinical studies demonstrating that FPI-1465 increases
the activity of...
Stellar Biotechnologies Presents at Annual 2013 National Science Foundation Conference
May 28, 2013 09:00 ET
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - May 28, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced the presentation of a poster at...
Stellar Biotechnologies Announces Publication of "Expert Review" Article on Clostridium Difficile Vaccines
April 30, 2013 09:00 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - Apr 30, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of Keyhole...
German Study Finds Bacteria on Seventy Percent of Dental Bib Holders
March 19, 2012 13:43 ET
|
DUX Dental
OXNARD, Calif., March 19, 2012 (GLOBE NEWSWIRE) -- This week, researchers at the University of Witten/Herdecke in North Rhine-Westphalia, Germany released a clinical study indicating that the...
New Research Indicates Potential for Continued Spread of Multidrug Resistant Strain of Staph Aureus
July 19, 2011 16:21 ET
|
Trius Therapeutics, Inc.
SAN DIEGO, July 19, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics...